Copyright Reports & Markets. All rights reserved.

Global Clinical Absorbable Hemostat Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Clinical Absorbable Hemostat
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Clinical Absorbable Hemostat Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Hemostatic Gauze
    • 1.3.3 Styptic Powder
    • 1.3.4 Gelatin
    • 1.3.5 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Clinical Absorbable Hemostat Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Clinical Absorbable Hemostat Market Size & Forecast
    • 1.5.1 Global Clinical Absorbable Hemostat Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Clinical Absorbable Hemostat Sales Quantity (2018-2029)
    • 1.5.3 Global Clinical Absorbable Hemostat Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Johnson & Johnson
    • 2.1.1 Johnson & Johnson Details
    • 2.1.2 Johnson & Johnson Major Business
    • 2.1.3 Johnson & Johnson Clinical Absorbable Hemostat Product and Services
    • 2.1.4 Johnson & Johnson Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Johnson & Johnson Recent Developments/Updates
  • 2.2 BD
    • 2.2.1 BD Details
    • 2.2.2 BD Major Business
    • 2.2.3 BD Clinical Absorbable Hemostat Product and Services
    • 2.2.4 BD Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 BD Recent Developments/Updates
  • 2.3 Baxter
    • 2.3.1 Baxter Details
    • 2.3.2 Baxter Major Business
    • 2.3.3 Baxter Clinical Absorbable Hemostat Product and Services
    • 2.3.4 Baxter Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Baxter Recent Developments/Updates
  • 2.4 B.Braun
    • 2.4.1 B.Braun Details
    • 2.4.2 B.Braun Major Business
    • 2.4.3 B.Braun Clinical Absorbable Hemostat Product and Services
    • 2.4.4 B.Braun Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 B.Braun Recent Developments/Updates
  • 2.5 Cura Medical
    • 2.5.1 Cura Medical Details
    • 2.5.2 Cura Medical Major Business
    • 2.5.3 Cura Medical Clinical Absorbable Hemostat Product and Services
    • 2.5.4 Cura Medical Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Cura Medical Recent Developments/Updates
  • 2.6 GELITA MEDICAL
    • 2.6.1 GELITA MEDICAL Details
    • 2.6.2 GELITA MEDICAL Major Business
    • 2.6.3 GELITA MEDICAL Clinical Absorbable Hemostat Product and Services
    • 2.6.4 GELITA MEDICAL Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 GELITA MEDICAL Recent Developments/Updates
  • 2.7 Curasan AG
    • 2.7.1 Curasan AG Details
    • 2.7.2 Curasan AG Major Business
    • 2.7.3 Curasan AG Clinical Absorbable Hemostat Product and Services
    • 2.7.4 Curasan AG Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Curasan AG Recent Developments/Updates
  • 2.8 Meril Life Sciences
    • 2.8.1 Meril Life Sciences Details
    • 2.8.2 Meril Life Sciences Major Business
    • 2.8.3 Meril Life Sciences Clinical Absorbable Hemostat Product and Services
    • 2.8.4 Meril Life Sciences Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Meril Life Sciences Recent Developments/Updates
  • 2.9 Zhonghui Shengxi
    • 2.9.1 Zhonghui Shengxi Details
    • 2.9.2 Zhonghui Shengxi Major Business
    • 2.9.3 Zhonghui Shengxi Clinical Absorbable Hemostat Product and Services
    • 2.9.4 Zhonghui Shengxi Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Zhonghui Shengxi Recent Developments/Updates
  • 2.10 Beijing Datsing Bio-tech
    • 2.10.1 Beijing Datsing Bio-tech Details
    • 2.10.2 Beijing Datsing Bio-tech Major Business
    • 2.10.3 Beijing Datsing Bio-tech Clinical Absorbable Hemostat Product and Services
    • 2.10.4 Beijing Datsing Bio-tech Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Beijing Datsing Bio-tech Recent Developments/Updates
  • 2.11 Guizhou Jin Jiu Biotech
    • 2.11.1 Guizhou Jin Jiu Biotech Details
    • 2.11.2 Guizhou Jin Jiu Biotech Major Business
    • 2.11.3 Guizhou Jin Jiu Biotech Clinical Absorbable Hemostat Product and Services
    • 2.11.4 Guizhou Jin Jiu Biotech Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Guizhou Jin Jiu Biotech Recent Developments/Updates
  • 2.12 Beijing Taikesiman
    • 2.12.1 Beijing Taikesiman Details
    • 2.12.2 Beijing Taikesiman Major Business
    • 2.12.3 Beijing Taikesiman Clinical Absorbable Hemostat Product and Services
    • 2.12.4 Beijing Taikesiman Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Beijing Taikesiman Recent Developments/Updates
  • 2.13 Foryou Medical
    • 2.13.1 Foryou Medical Details
    • 2.13.2 Foryou Medical Major Business
    • 2.13.3 Foryou Medical Clinical Absorbable Hemostat Product and Services
    • 2.13.4 Foryou Medical Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Foryou Medical Recent Developments/Updates
  • 2.14 Saikesaisi Holdings Group
    • 2.14.1 Saikesaisi Holdings Group Details
    • 2.14.2 Saikesaisi Holdings Group Major Business
    • 2.14.3 Saikesaisi Holdings Group Clinical Absorbable Hemostat Product and Services
    • 2.14.4 Saikesaisi Holdings Group Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Saikesaisi Holdings Group Recent Developments/Updates
  • 2.15 Biotemed
    • 2.15.1 Biotemed Details
    • 2.15.2 Biotemed Major Business
    • 2.15.3 Biotemed Clinical Absorbable Hemostat Product and Services
    • 2.15.4 Biotemed Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Biotemed Recent Developments/Updates
  • 2.16 Hangzhou Singclean Medical Products
    • 2.16.1 Hangzhou Singclean Medical Products Details
    • 2.16.2 Hangzhou Singclean Medical Products Major Business
    • 2.16.3 Hangzhou Singclean Medical Products Clinical Absorbable Hemostat Product and Services
    • 2.16.4 Hangzhou Singclean Medical Products Clinical Absorbable Hemostat Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Hangzhou Singclean Medical Products Recent Developments/Updates

3 Competitive Environment: Clinical Absorbable Hemostat by Manufacturer

  • 3.1 Global Clinical Absorbable Hemostat Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Clinical Absorbable Hemostat Revenue by Manufacturer (2018-2023)
  • 3.3 Global Clinical Absorbable Hemostat Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Clinical Absorbable Hemostat by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Clinical Absorbable Hemostat Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Clinical Absorbable Hemostat Manufacturer Market Share in 2022
  • 3.5 Clinical Absorbable Hemostat Market: Overall Company Footprint Analysis
    • 3.5.1 Clinical Absorbable Hemostat Market: Region Footprint
    • 3.5.2 Clinical Absorbable Hemostat Market: Company Product Type Footprint
    • 3.5.3 Clinical Absorbable Hemostat Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Clinical Absorbable Hemostat Market Size by Region
    • 4.1.1 Global Clinical Absorbable Hemostat Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Clinical Absorbable Hemostat Consumption Value by Region (2018-2029)
    • 4.1.3 Global Clinical Absorbable Hemostat Average Price by Region (2018-2029)
  • 4.2 North America Clinical Absorbable Hemostat Consumption Value (2018-2029)
  • 4.3 Europe Clinical Absorbable Hemostat Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Clinical Absorbable Hemostat Consumption Value (2018-2029)
  • 4.5 South America Clinical Absorbable Hemostat Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Clinical Absorbable Hemostat Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Clinical Absorbable Hemostat Sales Quantity by Type (2018-2029)
  • 5.2 Global Clinical Absorbable Hemostat Consumption Value by Type (2018-2029)
  • 5.3 Global Clinical Absorbable Hemostat Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Clinical Absorbable Hemostat Sales Quantity by Application (2018-2029)
  • 6.2 Global Clinical Absorbable Hemostat Consumption Value by Application (2018-2029)
  • 6.3 Global Clinical Absorbable Hemostat Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Clinical Absorbable Hemostat Sales Quantity by Type (2018-2029)
  • 7.2 North America Clinical Absorbable Hemostat Sales Quantity by Application (2018-2029)
  • 7.3 North America Clinical Absorbable Hemostat Market Size by Country
    • 7.3.1 North America Clinical Absorbable Hemostat Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Clinical Absorbable Hemostat Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Clinical Absorbable Hemostat Sales Quantity by Type (2018-2029)
  • 8.2 Europe Clinical Absorbable Hemostat Sales Quantity by Application (2018-2029)
  • 8.3 Europe Clinical Absorbable Hemostat Market Size by Country
    • 8.3.1 Europe Clinical Absorbable Hemostat Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Clinical Absorbable Hemostat Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Clinical Absorbable Hemostat Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Clinical Absorbable Hemostat Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Clinical Absorbable Hemostat Market Size by Region
    • 9.3.1 Asia-Pacific Clinical Absorbable Hemostat Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Clinical Absorbable Hemostat Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Clinical Absorbable Hemostat Sales Quantity by Type (2018-2029)
  • 10.2 South America Clinical Absorbable Hemostat Sales Quantity by Application (2018-2029)
  • 10.3 South America Clinical Absorbable Hemostat Market Size by Country
    • 10.3.1 South America Clinical Absorbable Hemostat Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Clinical Absorbable Hemostat Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Clinical Absorbable Hemostat Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Clinical Absorbable Hemostat Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Clinical Absorbable Hemostat Market Size by Country
    • 11.3.1 Middle East & Africa Clinical Absorbable Hemostat Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Clinical Absorbable Hemostat Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Clinical Absorbable Hemostat Market Drivers
  • 12.2 Clinical Absorbable Hemostat Market Restraints
  • 12.3 Clinical Absorbable Hemostat Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Clinical Absorbable Hemostat and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Clinical Absorbable Hemostat
  • 13.3 Clinical Absorbable Hemostat Production Process
  • 13.4 Clinical Absorbable Hemostat Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Clinical Absorbable Hemostat Typical Distributors
  • 14.3 Clinical Absorbable Hemostat Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Clinical Absorbable Hemostat market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Absorbable hemostatic material is a kind of biomedical material that can be used to stop bleeding quickly and be absorbed by the human body within a certain period of time.
    This report is a detailed and comprehensive analysis for global Clinical Absorbable Hemostat market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Clinical Absorbable Hemostat market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Clinical Absorbable Hemostat market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Clinical Absorbable Hemostat market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Clinical Absorbable Hemostat market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Clinical Absorbable Hemostat
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Clinical Absorbable Hemostat market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, BD, Baxter, B.Braun and Cura Medical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Clinical Absorbable Hemostat market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Hemostatic Gauze
    Styptic Powder
    Gelatin
    Other
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    Johnson & Johnson
    BD
    Baxter
    B.Braun
    Cura Medical
    GELITA MEDICAL
    Curasan AG
    Meril Life Sciences
    Zhonghui Shengxi
    Beijing Datsing Bio-tech
    Guizhou Jin Jiu Biotech
    Beijing Taikesiman
    Foryou Medical
    Saikesaisi Holdings Group
    Biotemed
    Hangzhou Singclean Medical Products
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Clinical Absorbable Hemostat product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Clinical Absorbable Hemostat, with price, sales, revenue and global market share of Clinical Absorbable Hemostat from 2018 to 2023.
    Chapter 3, the Clinical Absorbable Hemostat competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Clinical Absorbable Hemostat breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Clinical Absorbable Hemostat market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Clinical Absorbable Hemostat.
    Chapter 14 and 15, to describe Clinical Absorbable Hemostat sales channel, distributors, customers, research findings and conclusion.

    Buy now